Literature DB >> 15774266

Extended analyses support the association of a functional (GT)n polymorphism in the GRIN2A promoter with Japanese schizophrenia.

Yoshimi Iwayama-Shigeno1, Kazuo Yamada, Masanari Itokawa, Tomoko Toyota, Joanne M A Meerabux, Yoshio Minabe, Norio Mori, Toshio Inada, Takeo Yoshikawa.   

Abstract

Dysfunction of the N-methyl-D-aspartate (NMDA) type glutamate receptor has been proposed as a mechanism in the etiology of schizophrenia. Recently, we identified a variable (GT)n repeat in the promoter region of the NMDA NR2A subunit gene (GRIN2A), and showed its association with schizophrenia in a case-control study, together with a correlation between the length of the repeat and severity of chronic outcome. In this study, we extended our analyses, by increasing the number of case-control samples to a total of 672 schizophrenics and 686 controls, and excluded potential sample stratification effects. We confirmed the significant allelic association between the repeat polymorphism and disease (P = 0.011), and as in the previous study, we observed an over-representation of longer alleles in schizophrenia. These results suggest a probable genetic effect for the GRIN2A promoter (GT)n variation on the predisposition to schizophrenia in Japanese cohorts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774266     DOI: 10.1016/j.neulet.2004.12.013

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain.

Authors:  Sruti Rayaprolu; Sara Bitarafan; Juliet V Santiago; Ranjita Betarbet; Sydney Sunna; Lihong Cheng; Hailian Xiao; Ruth S Nelson; Prateek Kumar; Pritha Bagchi; Duc M Duong; Annie M Goettemoeller; Viktor János Oláh; Matt Rowan; Allan I Levey; Levi B Wood; Nicholas T Seyfried; Srikant Rangaraju
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

2.  The identification and functional implications of human-specific "fixed" amino acid substitutions in the glutamate receptor family.

Authors:  Hiroki Goto; Kazunori Watanabe; Naozumi Araragi; Rui Kageyama; Kunika Tanaka; Yoko Kuroki; Atsushi Toyoda; Masahira Hattori; Yoshiyuki Sakaki; Asao Fujiyama; Yasuyuki Fukumaki; Hiroki Shibata
Journal:  BMC Evol Biol       Date:  2009-09-08       Impact factor: 3.260

Review 3.  Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans.

Authors:  Ke Xu; Robert H Lipsky
Journal:  Exp Biol Med (Maywood)       Date:  2014-09-21

Review 4.  Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.

Authors:  L Watis; S H Chen; H C Chua; S A Chong; K Sim
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

5.  GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Authors:  M J Gandal; J Sisti; K Klook; P I Ortinski; V Leitman; Y Liang; T Thieu; R Anderson; R C Pierce; G Jonak; R E Gur; G Carlson; S J Siegel
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

Review 6.  Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.

Authors:  D A Forero; G Casadesus; G Perry; H Arboleda
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

7.  Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction.

Authors:  Bin Zhao; Yongsheng Zhu; Wei Wang; Hai-Min Cui; Yun-Peng Wang; Jiang-Hua Lai
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  In silico whole genome association scan for murine prepulse inhibition.

Authors:  Bradley Todd Webb; Joseph L McClay; Cristina Vargas-Irwin; Timothy P York; Edwin J C G van den Oord
Journal:  PLoS One       Date:  2009-04-16       Impact factor: 3.240

9.  Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

Authors:  C S Weickert; S J Fung; V S Catts; P R Schofield; K M Allen; L T Moore; K A Newell; D Pellen; X-F Huang; S V Catts; T W Weickert
Journal:  Mol Psychiatry       Date:  2012-10-16       Impact factor: 15.992

10.  Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population.

Authors:  Naomi Yamada-Fowler; Mats Fredrikson; Peter Söderkvist
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.